CLOROX CO /DE/ (CLX): debt financing — Clorox enters $1.2B five-year unsecured revolving credit facility, replaces prior agreement

CLOROX CO /DE/

New $1.2B five-year unsecured revolving credit agreement signed March 25, 2025 with JPMorgan, Citi, and Wells Fargo as administrative agents.
Prior $1.2B credit agreement (due March 2027) terminated concurrently; no material termination fees incurred.
Facility available for general corporate purposes; only financial covenant is a consolidated interest coverage ratio.
Interest rate options: base rate or Term SOFR plus applicable margin based on credit rating.
Agreement includes customary representations, covenants, and events of default; committed lenders include major banks.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

CLOROX CO /DE/ incurred revolving credit of $1,200,000,000 with JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association, as administrative agents, and lenders maturing five-year.

Instrument: revolving credit
Principal: $1,200,000,000
Counterparty: JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association, as administrative agents, and lenders
Maturity: five-year
Event: incurrence

Exact text from the filing

On March 25, 2025, The Clorox Company (“the Company”) entered into a $1,200,000,000 five-year unsecured revolving credit agreement (the “Agreement”) among JPMorgan Chase Bank, N.A., Citibank, N.A., and Wells Fargo Bank, National Association, as administrative agents, and lenders, and the other agents and lenders party thereto (the “Lenders”).

View on SEC.gov

103 debt financings filed in the last 30 days. Browse all debt financings →

CLOROX CO /DE/ filing history →

Source: SEC EDGAR

accession 0001206774-25-000171

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.